Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

Krsnaa Diagnostics

₹623.4 -16.9 | 2.6%

Market Cap ₹2013 Cr.

Stock P/E 35.0

P/B 2.5

Current Price ₹623.4

Book Value ₹ 250.8

Face Value 5

52W High ₹788.6

Dividend Yield 0.4%

52W Low ₹ 448.7

Krsnaa Diagnostics Research see more...

Overview Inc. Year: 2010Industry: Hospital & Healthcare Services

Krsnaa Diagnostics Ltd offers diagnostic offerings. The organisation gives a number of technology-enabled diagnostic services, which includes radiology, pathology/medical laboratory, and tele-radiology offerings to public and private hospitals, medical colleges, and community health centres. As of December 31, 2020, it operated 1,801 diagnostic facilities in thirteen states across India. The organization was established in 2010 and is primarily based in Pune, India.

Read More..

Krsnaa Diagnostics Share Price

New

| |

Volume
Price

Quarterly Price

Show Value Show %

Krsnaa Diagnostics Quarterly Results

#(Fig in Cr.) Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Net Sales 106 108 113 123 118 133 140 155 158 166
Other Income 4 4 5 4 5 6 4 4 4 4
Total Income 111 112 117 127 123 139 144 160 162 171
Total Expenditure 76 80 85 92 89 99 108 124 121 123
Operating Profit 34 32 32 35 34 40 36 36 41 48
Interest 2 2 1 2 2 2 2 3 4 7
Depreciation 11 10 12 13 14 15 16 19 21 18
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 21 20 19 20 18 24 18 13 16 23
Provision for Tax 5 2 4 5 4 5 3 3 3 4
Profit After Tax 16 18 14 15 14 19 15 10 13 19
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 16 18 14 15 14 19 15 10 13 19
Adjusted Earnings Per Share 5.2 5.7 4.5 4.9 4.3 6 4.7 3.3 4 5.8

Krsnaa Diagnostics Profit & Loss

#(Fig in Cr.) Mar 2022 Mar 2023 TTM
Net Sales 455 487 619
Other Income 15 19 16
Total Income 470 507 637
Total Expenditure 324 365 476
Operating Profit 146 142 161
Interest 18 8 16
Depreciation 41 54 74
Exceptional Income / Expenses 0 0 0
Profit Before Tax 87 80 70
Provision for Tax 18 18 13
Profit After Tax 68 62 57
Adjustments 0 0 0
Profit After Adjustments 68 62 57
Adjusted Earnings Per Share 21.8 19.8 17.8

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 7% 0% 0% 0%
Operating Profit CAGR -3% 0% 0% 0%
PAT CAGR -9% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 7% NA% NA% NA%
ROE Average 9% 9% 9% 9%
ROCE Average 12% 13% 13% 13%

Krsnaa Diagnostics Balance Sheet

#(Fig in Cr.) Mar 2022 Mar 2023
Shareholder's Funds 684 739
Minority's Interest 0 0
Borrowings 33 24
Other Non-Current Liabilities 37 46
Total Current Liabilities 121 99
Total Liabilities 875 909
Fixed Assets 386 471
Other Non-Current Assets 156 212
Total Current Assets 334 226
Total Assets 875 909

Krsnaa Diagnostics Cash Flow

#(Fig in Cr.) Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 25 88
Cash Flow from Operating Activities 128 76
Cash Flow from Investing Activities -241 -109
Cash Flow from Financing Activities 176 -33
Net Cash Inflow / Outflow 64 -66
Closing Cash & Cash Equivalent 88 23

Krsnaa Diagnostics Ratios

# Mar 2022 Mar 2023
Earnings Per Share (Rs) 21.78 19.78
CEPS(Rs) 34.96 36.91
DPS(Rs) 2.5 2.75
Book NAV/Share(Rs) 217.33 234.43
Core EBITDA Margin(%) 28.87 25.11
EBIT Margin(%) 23.05 18.04
Pre Tax Margin(%) 18.99 16.46
PAT Margin (%) 15.02 12.75
Cash Profit Margin (%) 24.1 23.79
ROA(%) 7.81 6.96
ROE(%) 10.02 8.76
ROCE(%) 14.47 11.75
Receivable days 46.38 49.07
Inventory Days 7.35 12.83
Payable days 467.93 343.02
PER(x) 22.29 23.26
Price/Book(x) 2.23 1.96
Dividend Yield(%) 0.51 0.6
EV/Net Sales(x) 2.91 2.81
EV/Core EBITDA(x) 9.04 9.66
Net Sales Growth(%) 0 6.95
EBIT Growth(%) 0 -16.29
PAT Growth(%) 0 -9.18
EPS Growth(%) 0 -9.18
Debt/Equity(x) 0.06 0.04
Current Ratio(x) 2.76 2.28
Quick Ratio(x) 2.69 2.02
Interest Cover(x) 5.68 11.42
Total Debt/Mcap(x) 0.03 0.02

Krsnaa Diagnostics Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 27.38 27.38 27.38 27.8 27.8 27.8 27.8 27.8 27.03 27.03
FII 4.44 4.49 4.27 4.06 4.14 3.37 5.7 3.68 3.44 3.34
DII 30.14 28.64 27.36 20.42 19.4 18.5 19.76 18.73 16.58 15.37
Public 38.04 39.49 40.98 47.72 48.66 50.33 46.74 49.79 52.95 54.26
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Debtor days have improved from 467.93 to 343.02days.
  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Promoter holding is low: 27.03%.
  • Company has a low return on equity of 9% over the last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Krsnaa Diagnostics News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....